Publication date: Sep 09, 2019
Aim: Marijuana use has been postulated to modulate opioid use, dependence and withdrawal. Broad target drug testing results provide a unique perspective to identify any potential interaction between marijuana use and opioid use. Materials & methods: Using a dataset of approximately 800,000 urine drug test results collected from pain management patients of a time from of multiple years, creatinine corrected opioid levels were evaluated to determine if the presence of the primary marijuana marker 11-nor-carboxy-tetrahydrocannabinol (THC-COOH) was associated with statistical differences in excreted opioid concentrations. Results & conclusion: For each of the opioids investigated (codeine, morphine, hydrocodone, hydromorphone, oxycodone, oxymorphone, fentanyl and buprenorphine), marijuana use was associated with statistically significant lower urinary opiate levels than in samples without indicators of marijuana use.
Goggin, M.M., Shahriar, B.J., Stead, A., and Janis, G.C. Reduced urinary opioid levels from pain management patients associated with marijuana use. 03988. 2019 Pain Manag.
- Fentanyl as Sentinel: The Deadly Threat of Illegal Synthetic and Counterfeit Drugs
- Retrospective analysis reveals significant association of hypoglycemia with tramadol and methadone in contrast to other opioids.
- Study shows hazardous patterns of prescription opioid misuse in the US